Nearly 75% of pivotal cancer trials in past 5 years exclude people living with HIV
|
From 2020 to 2024, 72.6% of pivotal oncology trials
excluded people living with HIV; Trials for blood cancers,
immunomodulatory agents and those ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...